S&P 500   4,145.19
DOW   32,803.47
QQQ   324.34
What to Expect from the Markets in a Recession
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
China July exports rise, with trade surplus at record-high
Electric Vehicles Can Drive Alcoa Stock Higher
What's in Democrats' big bill? Climate, health care, savings
Is Apple Pointing to a Massive Recession in the U.S.? (Ad)
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Bangladesh seeks China help to repatriate Rohingya refugees
Is Apple Pointing to a Massive Recession in the U.S.? (Ad)
S&P 500   4,145.19
DOW   32,803.47
QQQ   324.34
What to Expect from the Markets in a Recession
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
China July exports rise, with trade surplus at record-high
Electric Vehicles Can Drive Alcoa Stock Higher
What's in Democrats' big bill? Climate, health care, savings
Is Apple Pointing to a Massive Recession in the U.S.? (Ad)
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Bangladesh seeks China help to repatriate Rohingya refugees
Is Apple Pointing to a Massive Recession in the U.S.? (Ad)
S&P 500   4,145.19
DOW   32,803.47
QQQ   324.34
What to Expect from the Markets in a Recession
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
China July exports rise, with trade surplus at record-high
Electric Vehicles Can Drive Alcoa Stock Higher
What's in Democrats' big bill? Climate, health care, savings
Is Apple Pointing to a Massive Recession in the U.S.? (Ad)
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Bangladesh seeks China help to repatriate Rohingya refugees
Is Apple Pointing to a Massive Recession in the U.S.? (Ad)
S&P 500   4,145.19
DOW   32,803.47
QQQ   324.34
What to Expect from the Markets in a Recession
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
China July exports rise, with trade surplus at record-high
Electric Vehicles Can Drive Alcoa Stock Higher
What's in Democrats' big bill? Climate, health care, savings
Is Apple Pointing to a Massive Recession in the U.S.? (Ad)
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Bangladesh seeks China help to repatriate Rohingya refugees
Is Apple Pointing to a Massive Recession in the U.S.? (Ad)

Nature's Sunshine Products - NATR Stock Forecast, Price & News

$10.79
-0.03 (-0.28%)
(As of 08/5/2022 03:59 PM ET)
Add
Compare
Today's Range
$10.70
$10.86
50-Day Range
$10.34
$12.67
52-Week Range
$10.17
$19.26
Volume
669 shs
Average Volume
63,038 shs
Market Capitalization
$210.14 million
P/E Ratio
9.99
Dividend Yield
N/A
Price Target
$24.50

Nature's Sunshine Products MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
127.1% Upside
$24.50 Price Target
Short Interest
Healthy
1.39% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.46 out of 5 stars

Medical Sector

211th out of 1,293 stocks

Pharmaceutical Preparations Industry

85th out of 619 stocks

NATR stock logo

About Nature's Sunshine Products (NASDAQ:NATR) Stock

Nature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. The company was founded in 1972 and is headquartered in Lehi, Utah.

Wall Street Analysts Forecast Growth

Separately, TheStreet cut Nature's Sunshine Products from a "b-" rating to a "c+" rating in a report on Friday, July 8th.

Nature's Sunshine Products Price Performance

Shares of NASDAQ:NATR opened at $10.79 on Monday. The business's fifty day moving average price is $11.14 and its two-hundred day moving average price is $14.58. The stock has a market cap of $210.14 million, a PE ratio of 9.99 and a beta of 0.79. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.24 and a current ratio of 2.17. Nature's Sunshine Products has a one year low of $10.17 and a one year high of $19.26.

Nature's Sunshine Products (NASDAQ:NATR - Get Rating) last posted its quarterly earnings data on Thursday, May 5th. The company reported ($0.03) earnings per share (EPS) for the quarter. The business had revenue of $110.49 million for the quarter. Nature's Sunshine Products had a return on equity of 15.71% and a net margin of 4.84%.

Receive NATR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nature's Sunshine Products and its competitors with MarketBeat's FREE daily newsletter.

NATR Stock News Headlines

Nature's Sunshine Goes Solar
Nature's Sunshine Products, Inc. (NATR)
Nature’s Sunshine: Q4 Earnings Snapshot
See More Headlines
Receive NATR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nature's Sunshine Products and its competitors with MarketBeat's FREE daily newsletter.

NATR Company Calendar

Last Earnings
8/07/2018
Today
8/08/2022
Next Earnings (Confirmed)
8/09/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Personal Products
Sector
Medical
Current Symbol
NASDAQ:NATR
CUSIP
63902710
Employees
850
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$24.50
High Stock Price Forecast
$24.50
Low Stock Price Forecast
$24.50
Forecasted Upside/Downside
+127.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$28.85 million
Pretax Margin
6.00%

Debt

Sales & Book Value

Annual Sales
$444.08 million
Cash Flow
$2.01 per share
Book Value
$8.17 per share

Miscellaneous

Free Float
18,421,000
Market Cap
$210.14 million
Optionable
Not Optionable
Beta
0.79

Key Executives

  • Mr. Terrence O. Moorehead (Age 59)
    Pres, CEO & Director
    Comp: $1.72M
  • Mr. Joseph W. Baty (Age 65)
    CFO, Exec. VP of Fin. & Treasurer
    Comp: $764.35k
  • Mr. Daniel C. Norman (Age 48)
    Exec. VP & Pres of Asia/Pacific (APAC)
    Comp: $574.31k
  • Trent McCausland
    Exec. Director, Head of Operations & COO
  • Mr. Nathan G. Brower (Age 42)
    Exec. VP, Gen. Counsel & Sec.
  • Ms. Tracee Comstock (Age 56)
    VP of HR
  • Mr. Bryant J. Yates (Age 49)
    Exec. VP & Pres of Europe
  • Ms. Lynda Marie Hammons (Age 67)
    Sr. VP of Global Quality & Regulatory Affairs
  • Mr. Richard Zhang
    Managing Director of China
  • Mr. Henry Zhou
    Managing Director of China for Synergy













NATR Stock - Frequently Asked Questions

Should I buy or sell Nature's Sunshine Products stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nature's Sunshine Products in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Nature's Sunshine Products stock.
View analyst ratings for Nature's Sunshine Products
or view top-rated stocks.

What is Nature's Sunshine Products' stock price forecast for 2022?

1 Wall Street analysts have issued 1 year price targets for Nature's Sunshine Products' stock. Their NATR stock forecasts range from $24.50 to $24.50. On average, they expect Nature's Sunshine Products' share price to reach $24.50 in the next twelve months. This suggests a possible upside of 127.1% from the stock's current price.
View analysts' price targets for Nature's Sunshine Products
or view top-rated stocks among Wall Street analysts.

How has Nature's Sunshine Products' stock price performed in 2022?

Nature's Sunshine Products' stock was trading at $18.50 at the beginning of 2022. Since then, NATR shares have decreased by 41.7% and is now trading at $10.79.
View the best growth stocks for 2022 here
.

When is Nature's Sunshine Products' next earnings date?

Nature's Sunshine Products is scheduled to release its next quarterly earnings announcement on Tuesday, August 9th 2022.
View our earnings forecast for Nature's Sunshine Products
.

How can I listen to Nature's Sunshine Products' earnings call?

Nature's Sunshine Products will be holding an earnings conference call on Tuesday, August 9th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 919-882-2331 with passcode "46139".

How were Nature's Sunshine Products' earnings last quarter?

Nature's Sunshine Products, Inc. (NASDAQ:NATR) posted its earnings results on Tuesday, August, 7th. The company reported ($0.08) earnings per share (EPS) for the quarter. The business had revenue of $91.27 million for the quarter. Nature's Sunshine Products had a net margin of 4.84% and a trailing twelve-month return on equity of 15.71%.

What is Terrence Moorehead's approval rating as Nature's Sunshine Products' CEO?

13 employees have rated Nature's Sunshine Products CEO Terrence Moorehead on Glassdoor.com. Terrence Moorehead has an approval rating of 86% among Nature's Sunshine Products' employees.

What other stocks do shareholders of Nature's Sunshine Products own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nature's Sunshine Products investors own include Amicus Therapeutics (FOLD), Gilead Sciences (GILD), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Akorn (AKRX), Bausch Health Companies (BHC), Catalyst Pharmaceuticals (CPRX), Exelixis (EXEL) and Global Blood Therapeutics (GBT).

What is Nature's Sunshine Products' stock symbol?

Nature's Sunshine Products trades on the NASDAQ under the ticker symbol "NATR."

Who are Nature's Sunshine Products' major shareholders?

Nature's Sunshine Products' stock is owned by a variety of retail and institutional investors. Top institutional investors include Paradigm Capital Management Inc. NY (5.81%), Euclidean Technologies Management LLC (0.77%), Skylands Capital LLC (0.58%), State Board of Administration of Florida Retirement System (0.53%), Strs Ohio (0.21%) and Exchange Traded Concepts LLC (0.19%). Company insiders that own Nature's Sunshine Products stock include Kristine F Hughes, Prescott Group Capital Managem and Wynnefield Partners Small Cap.
View institutional ownership trends for Nature's Sunshine Products
.

How do I buy shares of Nature's Sunshine Products?

Shares of NATR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nature's Sunshine Products' stock price today?

One share of NATR stock can currently be purchased for approximately $10.79.

How much money does Nature's Sunshine Products make?

Nature's Sunshine Products (NASDAQ:NATR) has a market capitalization of $210.14 million and generates $444.08 million in revenue each year. The company earns $28.85 million in net income (profit) each year or $1.08 on an earnings per share basis.

How many employees does Nature's Sunshine Products have?

Nature's Sunshine Products employs 850 workers across the globe.

How can I contact Nature's Sunshine Products?

Nature's Sunshine Products' mailing address is 2901 WEST BLUEGRASS BOULEVARD SUITE 100, LEHI UT, 84043. The official website for Nature's Sunshine Products is www.naturessunshine.com. The company can be reached via phone at (801) 341-7900, via email at investorrelations@natr.com, or via fax at 801-342-4305.

This page (NASDAQ:NATR) was last updated on 8/8/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.